Several studies reported an increase frequency of MEFV mutations among children of vasculitic and rheumatic diseases, like inflammatory bowel disease (IBD), polyarteritis nodosa (PAN), HSP and juvenile idiopathic arthritis (JIA) [7–9]. This evidence concerns the gene MEFV and polyarteritis nodosa.